Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Parallel, Double-Blind Study to Assess the Cognitive Effects of a Citicoline Supplement (Cognizin®) in Men and Women With Age-Associated Memory Impairment

NCT03369925 is registered in ClinicalTrials.gov with Kyowa Hakko Bio Co., Ltd. as lead sponsor.

NCT NCT03369925
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03369925 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Parallel, Double-Blind Study to Assess the Cognitive Effects of a Citicoline Supplement (Cognizin®) in Men and Women With Age-Associated Memory Impairment
Lead sponsor
Kyowa Hakko Bio Co., Ltd.
Phase
Not applicable
Overall status
Completed
Start date
January 2, 2018
Completion date
December 3, 2018
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy